India sees 4% dip in weekly cases as tally declines in NE

Weekly Covid-19 cases in the country fell by 4% after having registered a 7.5% spike last week, mainly due to a steep decline in cases in several northeastern states.

India recorded over 2.74 lakh cases during the week ended Sunday (August 2-8), registering a 4.2% decline from previous week, when the case count was 2.86 lakh. That week (July 26-August 1), fresh cases in the country had risen for the first time in 12 weeks on the back of a 27% surge in Kerala and smaller increases in Karnataka and a few states in the northeast.

In the current week, Kerala cases showed signs of plateauing, with a marginal 1% increase over the previous week. In absolute numbers, the state reported over 1.41 lakh cases, its highest weekly count since the last week of May. It accounted for over 51% of all new cases reported during the week.
The drop in weekly cases was mainly because of a decline in fresh infections in the northeast, with Sikkim reporting a fall of 43%, Tripura 32%, Arunachal Pradesh 26%, Manipur 25% and Mizoram 22%. Deaths during the week fell to 3,540, the lowest weekly toll in India since beginning of April.
India sees 4% dip in weekly cases as tally declines in NE

  • Related Posts

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Phase 2 results for LB-102 showed statistically significant reductions in PANSS total score across all doses with onset by week 1 and sustained through study end, alongside low rates of…

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise